ES1229784U - Nutritional supplement (Machine-translation by Google Translate, not legally binding) - Google Patents
Nutritional supplement (Machine-translation by Google Translate, not legally binding) Download PDFInfo
- Publication number
- ES1229784U ES1229784U ES201900145U ES201900145U ES1229784U ES 1229784 U ES1229784 U ES 1229784U ES 201900145 U ES201900145 U ES 201900145U ES 201900145 U ES201900145 U ES 201900145U ES 1229784 U ES1229784 U ES 1229784U
- Authority
- ES
- Spain
- Prior art keywords
- vitamin
- citrate
- food supplement
- powder
- curcuma
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 235000015872 dietary supplement Nutrition 0.000 title claims abstract description 16
- RXKJFZQQPQGTFL-UHFFFAOYSA-N Dihydroxyacetone Natural products OCC(=O)CO RXKJFZQQPQGTFL-UHFFFAOYSA-N 0.000 claims abstract description 13
- 229940120503 dihydroxyacetone Drugs 0.000 claims abstract description 9
- 239000000843 powder Substances 0.000 claims abstract description 9
- 239000004615 ingredient Substances 0.000 claims abstract description 8
- 102000008186 Collagen Human genes 0.000 claims abstract description 7
- 108010035532 Collagen Proteins 0.000 claims abstract description 7
- 229920001436 collagen Polymers 0.000 claims abstract description 7
- SQDAZGGFXASXDW-UHFFFAOYSA-N 5-bromo-2-(trifluoromethoxy)pyridine Chemical compound FC(F)(F)OC1=CC=C(Br)C=N1 SQDAZGGFXASXDW-UHFFFAOYSA-N 0.000 claims abstract description 6
- 229920001287 Chondroitin sulfate Polymers 0.000 claims abstract description 6
- 235000014375 Curcuma Nutrition 0.000 claims abstract description 6
- 229940059329 chondroitin sulfate Drugs 0.000 claims abstract description 6
- 241000190633 Cordyceps Species 0.000 claims abstract description 5
- LXNHXLLTXMVWPM-UHFFFAOYSA-N Vitamin B6 Natural products CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 claims abstract description 5
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 claims abstract description 5
- 235000000470 Vitis quadrangularis Nutrition 0.000 claims abstract description 5
- 239000000203 mixture Substances 0.000 claims abstract description 5
- 239000000825 pharmaceutical preparation Substances 0.000 claims abstract description 5
- RADKZDMFGJYCBB-UHFFFAOYSA-N pyridoxal hydrochloride Natural products CC1=NC=C(CO)C(C=O)=C1O RADKZDMFGJYCBB-UHFFFAOYSA-N 0.000 claims abstract description 5
- 235000019158 vitamin B6 Nutrition 0.000 claims abstract description 5
- 239000011726 vitamin B6 Substances 0.000 claims abstract description 5
- 235000005282 vitamin D3 Nutrition 0.000 claims abstract description 5
- 239000011647 vitamin D3 Substances 0.000 claims abstract description 5
- 229940011671 vitamin b6 Drugs 0.000 claims abstract description 5
- 229940021056 vitamin d3 Drugs 0.000 claims abstract description 5
- VFLDPWHFBUODDF-FCXRPNKRSA-N curcumin Chemical compound C1=C(O)C(OC)=CC(\C=C\C(=O)CC(=O)\C=C\C=2C=C(OC)C(O)=CC=2)=C1 VFLDPWHFBUODDF-FCXRPNKRSA-N 0.000 claims abstract description 4
- 229960002849 glucosamine sulfate Drugs 0.000 claims abstract description 4
- 239000000126 substance Substances 0.000 claims abstract description 4
- 239000001354 calcium citrate Substances 0.000 claims abstract description 3
- 235000013337 tricalcium citrate Nutrition 0.000 claims abstract description 3
- 229940088594 vitamin Drugs 0.000 claims abstract description 3
- 229930003231 vitamin Natural products 0.000 claims abstract description 3
- 235000013343 vitamin Nutrition 0.000 claims abstract description 3
- 239000011782 vitamin Substances 0.000 claims abstract description 3
- 150000003722 vitamin derivatives Chemical class 0.000 claims abstract description 3
- 244000163122 Curcuma domestica Species 0.000 claims abstract 4
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 claims description 8
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Natural products OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims description 7
- 239000004376 Sucralose Substances 0.000 claims description 5
- 235000019408 sucralose Nutrition 0.000 claims description 5
- 244000099147 Ananas comosus Species 0.000 claims description 4
- 235000007119 Ananas comosus Nutrition 0.000 claims description 4
- 229920000168 Microcrystalline cellulose Polymers 0.000 claims description 4
- 244000262406 Vitis quadrangularis Species 0.000 claims description 4
- RMRCNWBMXRMIRW-BYFNXCQMSA-M cyanocobalamin Chemical compound N#C[Co+]N([C@]1([H])[C@H](CC(N)=O)[C@]\2(CCC(=O)NC[C@H](C)OP(O)(=O)OC3[C@H]([C@H](O[C@@H]3CO)N3C4=CC(C)=C(C)C=C4N=C3)O)C)C/2=C(C)\C([C@H](C/2(C)C)CCC(N)=O)=N\C\2=C\C([C@H]([C@@]/2(CC(N)=O)C)CCC(N)=O)=N\C\2=C(C)/C2=N[C@]1(C)[C@@](C)(CC(N)=O)[C@@H]2CCC(N)=O RMRCNWBMXRMIRW-BYFNXCQMSA-M 0.000 claims description 4
- 235000019813 microcrystalline cellulose Nutrition 0.000 claims description 4
- 239000008108 microcrystalline cellulose Substances 0.000 claims description 4
- 229940016286 microcrystalline cellulose Drugs 0.000 claims description 4
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 claims description 3
- 229930003268 Vitamin C Natural products 0.000 claims description 3
- 229940046374 chromium picolinate Drugs 0.000 claims description 3
- 239000004337 magnesium citrate Substances 0.000 claims description 3
- 229960005336 magnesium citrate Drugs 0.000 claims description 3
- 235000002538 magnesium citrate Nutrition 0.000 claims description 3
- 235000019154 vitamin C Nutrition 0.000 claims description 3
- 239000011718 vitamin C Substances 0.000 claims description 3
- 229940068475 zinc citrate Drugs 0.000 claims description 3
- 235000006076 zinc citrate Nutrition 0.000 claims description 3
- 239000011746 zinc citrate Substances 0.000 claims description 3
- VYZAMTAEIAYCRO-UHFFFAOYSA-N Chromium Chemical compound [Cr] VYZAMTAEIAYCRO-UHFFFAOYSA-N 0.000 claims description 2
- KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 claims description 2
- 239000002211 L-ascorbic acid Substances 0.000 claims description 2
- 235000000069 L-ascorbic acid Nutrition 0.000 claims description 2
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 claims description 2
- 229930003779 Vitamin B12 Natural products 0.000 claims description 2
- MECHNRXZTMCUDQ-UHFFFAOYSA-N Vitamin D2 Natural products C1CCC2(C)C(C(C)C=CC(C)C(C)C)CCC2C1=CC=C1CC(O)CCC1=C MECHNRXZTMCUDQ-UHFFFAOYSA-N 0.000 claims description 2
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 claims description 2
- 229960005070 ascorbic acid Drugs 0.000 claims description 2
- 229910052804 chromium Inorganic materials 0.000 claims description 2
- 239000011651 chromium Substances 0.000 claims description 2
- 235000000639 cyanocobalamin Nutrition 0.000 claims description 2
- 239000011666 cyanocobalamin Substances 0.000 claims description 2
- 229960002104 cyanocobalamin Drugs 0.000 claims description 2
- 229960002061 ergocalciferol Drugs 0.000 claims description 2
- XUFQPHANEAPEMJ-UHFFFAOYSA-N famotidine Chemical compound NC(N)=NC1=NC(CSCCC(N)=NS(N)(=O)=O)=CS1 XUFQPHANEAPEMJ-UHFFFAOYSA-N 0.000 claims description 2
- 238000009472 formulation Methods 0.000 claims description 2
- 229910052749 magnesium Inorganic materials 0.000 claims description 2
- 239000011777 magnesium Substances 0.000 claims description 2
- 229940091250 magnesium supplement Drugs 0.000 claims description 2
- ZUFQODAHGAHPFQ-UHFFFAOYSA-N pyridoxine hydrochloride Chemical compound Cl.CC1=NC=C(CO)C(CO)=C1O ZUFQODAHGAHPFQ-UHFFFAOYSA-N 0.000 claims description 2
- 235000019171 pyridoxine hydrochloride Nutrition 0.000 claims description 2
- 239000011764 pyridoxine hydrochloride Substances 0.000 claims description 2
- 229960004172 pyridoxine hydrochloride Drugs 0.000 claims description 2
- BAQAVOSOZGMPRM-QBMZZYIRSA-N sucralose Chemical compound O[C@@H]1[C@@H](O)[C@@H](Cl)[C@@H](CO)O[C@@H]1O[C@@]1(CCl)[C@@H](O)[C@H](O)[C@@H](CCl)O1 BAQAVOSOZGMPRM-QBMZZYIRSA-N 0.000 claims description 2
- WGIWBXUNRXCYRA-UHFFFAOYSA-H trizinc;2-hydroxypropane-1,2,3-tricarboxylate Chemical compound [Zn+2].[Zn+2].[Zn+2].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O.[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O WGIWBXUNRXCYRA-UHFFFAOYSA-H 0.000 claims description 2
- 235000019163 vitamin B12 Nutrition 0.000 claims description 2
- 239000011715 vitamin B12 Substances 0.000 claims description 2
- 235000001892 vitamin D2 Nutrition 0.000 claims description 2
- 239000011653 vitamin D2 Substances 0.000 claims description 2
- MECHNRXZTMCUDQ-RKHKHRCZSA-N vitamin D2 Chemical compound C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)/C=C/[C@H](C)C(C)C)=C\C=C1\C[C@@H](O)CCC1=C MECHNRXZTMCUDQ-RKHKHRCZSA-N 0.000 claims description 2
- 239000011701 zinc Substances 0.000 claims description 2
- 229910052725 zinc Inorganic materials 0.000 claims description 2
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 claims 1
- 229960002303 citric acid monohydrate Drugs 0.000 claims 1
- 235000003373 curcuma longa Nutrition 0.000 claims 1
- 244000045483 Cissus quadrangularis Species 0.000 abstract 1
- 241000407170 Curcuma Species 0.000 description 3
- 239000013589 supplement Substances 0.000 description 3
- 241000207199 Citrus Species 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 239000004067 bulking agent Substances 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 235000010980 cellulose Nutrition 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 235000020971 citrus fruits Nutrition 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 235000003599 food sweetener Nutrition 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 150000004682 monohydrates Chemical class 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 229940127557 pharmaceutical product Drugs 0.000 description 1
- 239000003765 sweetening agent Substances 0.000 description 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Abstract
Description
SUPLEMENTO ALIMENTICIO NUTRITIONAL SUPPLEMENT
DESCRIPCIONDESCRIPTION
OBJETO DE LA INVENCIONOBJECT OF THE INVENTION
La invencion, tal como expresa el enunciado de la presente memoria descriptiva, se refiere a un suplemento alimenticio.The invention, as expressed in the wording of the present specification, refers to a food supplement.
Mas en particular, el objeto de la invencion se centra en un suplemento alimenticio a base de Colageno y Condroitin sulfato, entre otros ingredientes,More particularly, the object of the invention focuses on a food supplement based on collagen and chondroitin sulfate, among other ingredients,
CAMPO DE APLICACION DE LA INVENCIONFIELD OF APPLICATION OF THE INVENTION
El campo de aplicacion de la presente invencion se enmarca dentro del sector de la industria dedicada a la fabrication de productos farmaceuticos, centrandose particularmente en el ambito de los suplementos o complementos alimenticios.The field of application of the present invention is part of the sector of the industry dedicated to the manufacture of pharmaceutical products, focusing particularly on the field of supplements or food supplements.
ANTECEDENTES DE LA INVENCIONBACKGROUND OF THE INVENTION
Como referencia at estado actual de la tecnica, cabe senalar que, si bien existen en el mercado multitud de preparados farmaceuticos que constituyen complementos o suplementos alimenticios, algunos de ellos comprendiendo Colageno como ingrediente, al menos por parte del solicitante, se desconoce la existencia de ninguno que presente unas caracteristicas constitutivas iguales o semejantes a las que presenta el suplemento que aqui se reivindica.As a reference at the current state of the art, it should be noted that, although there are many pharmaceutical preparations in the market that constitute supplements or food supplements, some of them including Collagen as an ingredient, at least on the part of the applicant, the existence of none that presents a constitutive characteristics equal or similar to those presented by the supplement claimed here.
EXPLICACION DE LA INVENCIONEXPLANATION OF THE INVENTION
El suplemento alimenticio que la invencion propone consiste, concretamente, en un preparado farmaceutico que, preferentemente en forma de polvo y preferentemente comercializable envasado en sobres de dosis individuates, comprende, como ingredientes esenciales preferidos de su composition, las siguientes sustancias: The food supplement proposed by the invention consists, in particular, of a pharmaceutical preparation which, preferably in the form of a powder and preferably marketable, packaged in individual dose envelopes, comprises, as preferred essential ingredients of its composition, the following substances:
- Colageno Hidrolizado Peptan- Hydrolyzed Collagen Peptan
- Sulfato de Condroitina Marino- Marine Chondroitin Sulfate
- Sulfato de Glucosamina- Glucosamine sulfate
- Cordycep polvo- Cordycep powder
- Cissus Quadrangularis- Cissus Quadrangularis
- Celulosa Microcristalina- Microcrystalline cellulose
- Aroma de pina - naranja- Pineapple aroma - orange
- Citrato de Magnesio- Magnesium Citrate
- Vitamina C- Vitamin C
- Extracto de Curcuma- Curcuma Extract
- L- Arginina Base- L- Arginine Base
- Citrato Tricalcico- Tricalcium Citrate
- DHA (Dihidroxiacetona)- DHA (Dihydroxyacetone)
- Vitamina B6- Vitamin B6
- Citrato de Zinc- Zinc Citrate
- Acido Citrico- Citric acid
- Sucralosa- Sucralose
- Cromo Picolinato- Chromium Picolinate
- Vitamina D3- Vitamin D3
- Vitamina B12- B12 vitamin
Cabe mencionar que algunos de estas sustancias pueden no ser incluidas o ser sustituidas por otras semejantes, en concreto, por ejemplo, la Celulosa Microcristalina, ya que se trata de un ingrediente que sirve como agente de carga, el Aroma de pina o naranja, el Acido Citrico ya que serviria como corrector de la acidez o la Sucralosa que actua como edulcorante.It is worth mentioning that some of these substances may not be included or be replaced by similar ones, specifically, for example, Microcrystalline Cellulose, since it is an ingredient that serves as a bulking agent, the Pineapple or orange aroma, Citrus acid since it would serve as a corrector of acidity or Sucralose that acts as a sweetener.
En cualquier caso, la formulation del suplemento alimenticio objeto de la invencion, para un sobre de 6500mg, comprende, preferentemente, los mencionados ingredientes en el tipo concreto y las cantidades que se especifican a continuacion:In any case, the formulation of the food supplement object of the invention, for an envelope of 6500mg, preferably comprises the aforementioned ingredients in the specific type and the amounts specified below:
- Colageno Hidrolizado Peptan F 2500 mg- Hydrolyzed Collagen Peptan F 2500 mg
- Sulfato de Condroitina Marino 90% 400mg- Marine Chondroitin Sulfate 90% 400mg
- Sulfato de Glucosamina 2KCL DC 400 mg - Glucosamine Sulfate 2KCL DC 400 mg
- Cordycep polvo (7% maritol) Mycelium 400mg- Cordycep powder (7% maritol) Mycelium 400mg
- Cissus Quadrangularis Ext. Seco 10:1 (toda la planta) 400mg- Cissus Quadrangularis Ext. Dry 10: 1 (whole plant) 400mg
- Celulosa Microcristaiina (agente de carga)- Cellulose Microcristaiina (loading agent)
- Aroma de pina - naranja- Pineapple aroma - orange
- Citrato de Magnesio (48mg de Magnesio) 300mg- Magnesium Citrate (48mg Magnesium) 300mg
- Vitamina C (Acido L-ascorbico) (375% VRN) 300mg- Vitamin C (L-ascorbic acid) (375% VRN) 300mg
- Extracto de Curcuma 30:1 (Curcuma ionga 31%) rizoma 300mg- Extract of Curcuma 30: 1 (Curcuma ionga 31%) rhizome 300mg
- L- Arginina Base 300mg- L- Arginine Base 300mg
- Citrato triciilcico 200mg- Tricyclic Citrate 200mg
- DHA (Dihidroxiacetona) 13% polvo 100mg- DHA (Dihydroxyacetone) 13% powder 100mg
- Vitamina B6 (Piridoxina Clorhidrato) (3471,43% VRN) 50mg- Vitamin B6 (Pyridoxine Hydrochloride) (3471.43% VRN) 50mg
- Citrato de Zinc 32% (15,5mg de Zinc) 50mg- 32% Zinc Citrate (15.5mg Zinc) 50mg
- Acido Citrico Monohidrato (corrector de la acidez E-330)- Citrus Monohydrate Acid (acidity corrector E-330)
- Sucralosa (dulcorante)- Sucralose (sweet)
- Cromo Picolinato 99,6% (0,025mg de Cromo) 0,2mg- Chromium Picolinate 99.6% (0.025 mg of Chromium) 0.2 mg
- Vitamina D3 (Ergocalciferol Clecalciferol (100% VRN) 0,005mg- Vitamin D3 (Ergocalciferol Clecalciferol (100% VRN) 0.005mg
- Vitamina B12 (Cianocobalamina) (200% VRN) 0,005mg- Vitamin B12 (cyanocobalamin) (200% VRN) 0.005 mg
Conviene aclarar que las sigias VRN, hacen referencia al valor nutricional de referencia.It should be clarified that the following VRN refer to the nutritional value of reference.
Descrita suficientemente la naturaleza de la presente invencidn, asi como la manera de ponerla en practica, no se considera necesario hacer mas extensa su explicacion para que cualquier experto en la materia comprenda su alcance y las ventajas que de ella se derivan, haciendose constar que podra ser Nevada a la practica en otras formas de realizacidn que difieran en detalle de la indicada a titulo de ejemplo siempre que no se modifique lo fundamental. Having sufficiently described the nature of the present invention, as well as the way of putting it into practice, it is not considered necessary to make its explanation more extensive so that any expert in the field understands its scope and the advantages derived from it, stating that Be Nevada to practice in other forms of performance that differ in detail from that indicated by way of example provided that the fundamental is not modified.
Claims (7)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ES201900145U ES1229784Y (en) | 2019-03-11 | 2019-03-11 | Nutritional supplement |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ES201900145U ES1229784Y (en) | 2019-03-11 | 2019-03-11 | Nutritional supplement |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| ES1229784U true ES1229784U (en) | 2019-05-21 |
| ES1229784Y ES1229784Y (en) | 2019-08-09 |
Family
ID=66518946
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES201900145U Active ES1229784Y (en) | 2019-03-11 | 2019-03-11 | Nutritional supplement |
Country Status (1)
| Country | Link |
|---|---|
| ES (1) | ES1229784Y (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2813567C1 (en) * | 2022-09-09 | 2024-02-13 | Общество С Ограниченной Ответственностью "Анвилаб" | Dietary supplement with chondroprotective action and method of its use |
-
2019
- 2019-03-11 ES ES201900145U patent/ES1229784Y/en active Active
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2813567C1 (en) * | 2022-09-09 | 2024-02-13 | Общество С Ограниченной Ответственностью "Анвилаб" | Dietary supplement with chondroprotective action and method of its use |
Also Published As
| Publication number | Publication date |
|---|---|
| ES1229784Y (en) | 2019-08-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Birringer | Hormetics: dietary triggers of an adaptive stress response | |
| US7273606B2 (en) | Solubilized CoQ-10 and carnitine | |
| JP6125760B2 (en) | Carotenoid compositions and methods for protecting the skin | |
| KR20180019217A (en) | Composition for soft capsule coating | |
| TWI508670B (en) | Nutritional powder containing spray dried HMB | |
| JP2008542300A (en) | Compositions and methods for preventing and treating conditions associated with inflammation | |
| JP2015131825A5 (en) | ||
| ES1229784U (en) | Nutritional supplement (Machine-translation by Google Translate, not legally binding) | |
| JP2006212021A (en) | Food composition | |
| CN105876382A (en) | Brand new nutrition type flavoring containing mushrooms | |
| ES1304155U (en) | ENCAPSULATED FOOD SUPPLEMENT (Machine-translation by Google Translate, not legally binding) | |
| Cetin et al. | Effects of grape seed extract and Origanum onites essential oil on cisplatin-induced hepatotoxicity in rats | |
| US9770434B2 (en) | Compositions for improved body composition | |
| Milner | Garlic (Allium sativum) | |
| EP3182966B1 (en) | A composition for the prevention and treatment of metabolic disorders associated with menopause and climacteric | |
| JP2006230225A (en) | A food containing a component having an inhibitory effect on an increase in blood glucose level | |
| Donkor et al. | Antioxidant potentials of tomato paste extracts found on major markets in Accra Metropolis | |
| Lim | Allium sativum | |
| WO2020077156A1 (en) | Supplement | |
| BR102024010846A2 (en) | SOLID COMPOSITION, METHOD OF PREPARATION AND ITS USE FOR ORAL SUPPLEMENTATION | |
| Raina et al. | Role of polyphenols in modulating AGEs-RAGE axis in cancer, a review | |
| Trivedi et al. | Spices and Herbs in Bacterial and Fungal Resistance | |
| Kaur | Chemopreventive Effects of Mushrooms on Breast Cancer | |
| ES1304020U (en) | FOOD SUPPLEMENT POWDER (Machine-translation by Google Translate, not legally binding) | |
| US11951144B2 (en) | Composition, food supplement, composition acting as a food supplement for children, and production method |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PC1K | Transfer of utility model |
Owner name: CESAR ANDARCIA BANUELOS Effective date: 20190510 |
|
| CA1K | Utility model application published |
Ref document number: 1229784 Country of ref document: ES Kind code of ref document: U Effective date: 20190521 |
|
| FG1K | Utility model granted |
Ref document number: 1229784 Country of ref document: ES Kind code of ref document: Y Effective date: 20190805 |